Innodata Inc. announced that a Fortune 500 insurance company has expanded its scope of services with Innodata to support its medical record predictive model development. The expansion adds approximately $700,000 of anticipated one-time revenue to the revenue estimates previously announced on September 15, 2021 of approximately $3 million of one-time revenue and $800,000 per year of ongoing annual revenue.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.5 USD | -3.96% |
|
+24.64% | +155.41% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+155.41% | 614M | |
-7.39% | 204B | |
+10.15% | 181B | |
+13.68% | 171B | |
+6.41% | 101B | |
+41.16% | 89.81B | |
+13.41% | 85.57B | |
+11.87% | 85.54B | |
+7.06% | 50.83B | |
-30.74% | 45.61B |
- Stock Market
- Equities
- INOD Stock
- News Innodata Inc.
- Innodata Expands Scope with Fortune 500 Client